Selective 5-hydroxytryptamine2 antagonists have antidepressant-like effects on differential-reinforcement-of-low-rate 72-second schedule

GJ Marek, AA Li and LS Seiden

University of Chicago, Department of Pharmacological and Physiological Sciences, Illinois.

The effects of eleven 5-hydroxytryptamine antagonists with varying selectivity for the 5-hydroxytryptamine2 (5-HT2) relative to the 5-HT1 binding site were assessed in rats responding under a differential- reinforcement-of-low rate 72-sec (DRL 72-s) schedule of reinforcement. Three drugs with a 1000-fold selectivity for the 5-HT2 binding site (ketanserin, ritanserin, pipamperone) increased the reinforcement rate and decreased the response rate similar to antidepressant drugs. The two drugs with roughly the same affinity for both 5-HT1 and 5-HT2 binding sites (methysergide and metergoline) did not increase the reinforcement rate. The maximal increase in the reinforcement rate after 5-HT antagonist administration was positively correlated with the selectivity of the 5-HT antagonists for the 5-HT2 versus the 5-HT1 binding site. The increase in the reinforcement rate after administration of 5-HT antagonists was not correlated with the affinity of the 5-HT antagonists for the alpha-1 adrenergic, alpha-2 adrenergic, histamine-1 or dopamine-2 receptors. The 1000-fold selective 5-HT2 antagonist xylamidine, which does not pass the blood-brain barrier, did not increase the reinforcement rate or decrease the response rate. Thus, selective antagonism of central 5-HT2 relative to 5-HT1 receptors results in antidepressant-like effects on the DRL 72-s schedule. Furthermore, the specificity of the DRL 72-s schedule as a screen for antidepressant drugs was strengthened by the observation that the alpha- 1 adrenergic antagonist, prazosin, did not increase the reinforcement rate despite significant decreases in the response rate.

Volume 250, Issue 1, pp. 52-59, 07/01/1989
Copyright © 1989 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				M. Balcells-Olivero, M. S. Cousins, and L. S. Seiden Holtzman and Harlan Sprague-Dawley Rats: Differences in DRL 72-Sec Performance and 8-Hydroxy-Di-Propylamino Tetralin-Induced Hypothermia J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 742 - 752. [Abstract] [Full Text]

				M. J. Millan, A. Newman-Tancredi, J.-M. Rivet, M. Brocco, P. Lacroix, V. Audinot, L. Cistarelli, and A. Gobert S 15535, A Novel Benzodioxopiperazine Ligand of Serotonin (5-HT)1A Receptors: I. Interaction with Cloned Human (h)5-HT1A, Dopamine hD2/hD3 and halpha 2A-Adrenergic Receptors in Relation to Modulation of Cortical Monoamine Release and Activity in Models of Potential Antidepressant Activity J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 132 - 147. [Abstract] [Full Text]

				M. A. Da-Rocha Jr, A. J. Puech, and M.-H. Thiebot Influence of anxiolytic drugs on the effects of specific serotonin reuptake inhibitors in the forced swimming test in mice J Psychopharmacol, January 1, 1997; 11(3): 211 - 218. [Abstract] [PDF]